Literature DB >> 1720134

Expression of immunomolecules on microglial cells following neonatal sciatic nerve axotomy.

T Morioka1, W J Streit.   

Abstract

We have examined the microglial reaction accompanying motor neuron death following sciatic nerve crush in the newborn rat using lectin staining with the Griffonia simplicifolia B4-isolectin, as well as immunocytochemistry with a panel of monoclonal antibodies directed against brain macrophage antigen (ED2), and various immunologically important surface molecules (immunomolecules), such as major histocompatibility complex (MHC) class II (Ia) antigen (OX-6), CR3 complement receptor (OX-42), CD4 antigen (W3/25), and leukocyte common antigen (OX-1). The lectin histochemical method provided the earliest indication of a microglial response by demonstrating increased microglial density and clustering around dying motoneurons as early as 2 days after lesioning. Most immunomolecules were largely undetectable in the normal and early post-lesion spinal cord; however, at post-lesion day 5 localized expression of Ia antigen was visualized in the area of degenerating motor neurons. Ia expression preceded the appearance of other immunomolecules at day 8. No increase in staining with the ED2 antibody for macrophage antigen could be detected at any post-lesion interval. When compared to the microglial activation that occurs after axotomy in adult animals, our results show a similar onset in microglial activation in neonatal animals; however, the duration of immunomolecule expression is much briefer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720134     DOI: 10.1016/0165-5728(91)90158-4

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  9 in total

1.  Immunophenotypic analysis of infiltrating leukocytes and microglia in an experimental rat glioma.

Authors:  T Morioka; T Baba; K L Black; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Posthypoxic cooling of neonatal rats provides protection against brain injury.

Authors:  M Thoresen; R Bågenholm; E M Løberg; F Apricena; I Kjellmer
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-01       Impact factor: 5.747

Review 3.  The role of macrophage subpopulations in autoimmune disease of the central nervous system.

Authors:  J Bauer; S R Ruuls; I Huitinga; C D Dijkstra
Journal:  Histochem J       Date:  1996-02

4.  Eicosanoids and nitric oxide influence induction of reactive gliosis from spreading depression in microglia but not astrocytes.

Authors:  A O Caggiano; R P Kraig
Journal:  J Comp Neurol       Date:  1996-05-20       Impact factor: 3.215

5.  Prostaglandin E2 and 4-aminopyridine prevent the lipopolysaccharide-induced outwardly rectifying potassium current and interleukin-1beta production in cultured rat microglia.

Authors:  A O Caggiano; R P Kraig
Journal:  J Neurochem       Date:  1998-06       Impact factor: 5.372

Review 6.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

7.  Immunophenotypic features of epiplexus cells and their response to interferon gamma injected intraperitoneally in postnatal rats.

Authors:  J Lu; C Kaur; E A Ling
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

8.  Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide.

Authors:  J Xu; E A Ling
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

Review 9.  Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology.

Authors:  R H Garman; A S Fix; B S Jortner; K F Jensen; J F Hardisty; L Claudio; S Ferenc
Journal:  Environ Health Perspect       Date:  2001-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.